Mitochondrial targeted peptides attenuate residual myocardial damage after reversal of experimental renovascular hypertension

Journal of Hypertension

Volumn 32, Issue 1, 2014, Pages 154-165

  Eirin, Alfonso ^a   Williams, Barbara J ^a   Ebrahimi, Behzad ^a   Zhang, Xin ^a   Crane, John A ^a   Lerman, Amir ^a   Textor, Stephen C ^a   Lerman, Lilach O ^a  

^a MAYO CLINIC   (United States)

Author keywords

Mitochondria; Myocardium; Renal hypertension; Revascularization

Indexed keywords

ELAMIPRETIDE; COLLAGEN; OXYGEN; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTERY SURGERY; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EX VIVO STUDY; FEMALE; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; KIDNEY ARTERY; MITOCHONDRIAL BIOGENESIS; MORPHOLOGY; MULTIDETECTOR COMPUTED TOMOGRAPHY; MYOCARDITIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; OXYGEN BLOOD LEVEL; OXYGENATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL RENAL ANGIOPLASTY; PRIORITY JOURNAL; RENAL ARTERY REVASCULARIZATION; RENOVASCULAR HYPERTENSION; SYSTOLIC BLOOD PRESSURE; VASCULAR STENT; ANGIOPLASTY; ANIMAL; CARDIOMYOPATHY; FIBROSIS; HEART FUNCTION TEST; HEART MITOCHONDRION; KIDNEY FUNCTION TEST; METABOLISM; MICROVASCULATURE; PATHOLOGY; SWINE; ULTRASTRUCTURE;

ANGIOPLASTY; ANIMALS; APOPTOSIS; CARDIOMYOPATHIES; COLLAGEN; FEMALE; FIBROSIS; HEART FUNCTION TESTS; HYPERTENSION, RENOVASCULAR; KIDNEY FUNCTION TESTS; MICROVESSELS; MITOCHONDRIA, HEART; OXIDATIVE STRESS; OXYGEN; PEPTIDES; SWINE;

EID: 84905132634     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283658a53     Document Type: Article

References (43)

1. Kalra PA, Guo H, Kausz AT, Gilbertson DT, Liu J, Chen SC, et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int 2005;68:293-301.
2. Green D, Kalra PA. The heart in atherosclerotic renovascular disease. Front Biosci (Elite Ed) 2012;4:856-864.
3. Koivuviita N, Tertti R, Luotolahti M, Raitakari O, Vahlberg T, Nuutila P, et al. The effect of revascularization of atherosclerotic renal artery stenosis on coronary flow reserve and peripheral endothelial function. Nephron Clin Pract 2011;118:c241-c248.
4. Corriere MA, Hoyle JR, Craven TE, D'Agostino RB Jr, Edwards MS, Moore PS, Hansen KJ. Changes in left ventricular structure and function following renal artery revascularization. Ann Vasc Surg 2010;24:80-84.
5. Kane GC, Xu N, Mistrik E, Roubicek T, Stanson AW, Garovic VD. Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis. Nephrol Dial Transplant 2010;25:813-820.
6. Eirin A, Li Z, Zhang X, Krier JD, Woollard JR, Zhu XY, et al. A mitochondrial permeability transition pore inhibitor improves renal outcomes after revascularization in experimental atherosclerotic renal artery stenosis. Hypertension 2012;60:1242-1249.
7. Lin J, Zhu X, Chade AR, Jordan KL, Lavi R, Daghini E, et al. Monocyte chemoattractant proteins mediate myocardial microvascular dysfunction in swine renovascular hypertension. Arterioscler Thromb Vasc Biol 2009;29:1810-1816.
8. Urbieta-Caceres VH, Zhu XY, Jordan KL, Tang H, Textor K, Lerman A, Lerman LO. Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease. Atherosclerosis 2012;221:350-358.
9. Szeto HH, Liu S, Soong Y, Wu D, Darrah SF, Cheng FY, et al. Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. J Am Soc Nephrol 2011;22:1041-1052.
10. Szeto HH. Mitochondria-targeted cytoprotective peptides for ischemiareperfusion injury. Antioxid Redox Signal 2008;10:601-619.
11. Baines CP. The molecular composition of the mitochondrial permeability transition pore. J Mol Cell Cardiol 2009;46:850-857.
12. Dai DF, Chen T, Szeto H, Nieves-Cintron M, Kutyavin V, Santana LF, Rabinovitch PS. Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy. J Am Coll Cardiol 2011;58:73-82.
13. Kloner RA, Hale SL, Dai W, Gorman RC, Shuto T, Koomalsingh KJ, et al. Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective peptide. J Am Heart Assoc 2012;1:e001644.
14. Heusch G, Boengler K, Schulz R. Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection. Basic Res Cardiol 2010;105:151-154.
15. Lerman LO, Schwartz RS, Grande JP, Sheedy PF, Romero JC. Noninvasive evaluation of a novel swine model of renal artery stenosis. J Am Soc Nephrol 1999;10:1455-1465.
16. Eirin A, Ebrahimi B, Zhang X, Zhu XY, Tang H, Crane JA, et al. Changes in glomerular filtration rate after renal revascularization correlate with microvascular hemodynamics and inflammation in swine renal artery stenosis. Circ Cardiovasc Interv 2012;5:720-728.
17. Eirin A, Zhu XY, Urbieta-Caceres VH, Grande JP, Lerman A, Textor SC, Lerman LO. Persistent kidney dysfunction in swine renal artery stenosis correlates with outer cortical microvascular remodeling. Am J Physiol Renal Physiol 2011;300:F1394-F1401.
18. Li ZL, Woollard JR, Ebrahimi B, Crane JA, Jordan KL, Lerman A, et al. Transition from obesity to metabolic syndrome is associated with altered myocardial autophagy and apoptosis. Arterioscler Thromb Vasc Biol 2012;32:1132-1141.
19. Rodriguez-Porcel M, Herrman J, Chade AR, Krier JD, Breen JF, Lerman A, Lerman LO. Long-term antioxidant intervention improves myocardial microvascular function in experimental hypertension. Hypertension 2004;43:493-498.
20. Zhu XY, Daghini E, Chade AR, Napoli C, Ritman EL, Lerman A, Lerman LO. Simvastatin prevents coronary microvascular remodeling in renovascular hypertensive pigs. J Am Soc Nephrol 2007;18:1209-1217.
21. Daghini E, Primak AN, Chade AR, Krier JD, Zhu XY, Ritman EL, et al. Assessment of renal hemodynamics and function in pigs with 64-section multidetector CT: comparison with electron-beam CT. Radiology 2007;243:405-412.
22. Zhu XY, Daghini E, Chade AR, Versari D, Krier JD, Textor KB, et al. Myocardial microvascular function during acute coronary artery stenosis: effect of hypertension and hypercholesterolaemia. Cardiovasc Res 2009;83:371-380.
23. Eirin A, Zhu XY, Krier JD, Tang H, Jordan KL, Grande JP, et al. Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells 2012;30:1030-1041.
24. Ebrahimi B, Li Z, Eirin A, Zhu XY, Textor SC, Lerman LO. Addition of endothelial progenitor cells to renal revascularization restores medullary tubular oxygen consumption in swine renal artery stenosis. Am J Physiol Renal Physiol 2012;302:F1478-F1485.
25. Zhu XY, Rodriguez-Porcel M, Bentley MD, Chade AR, Sica V, Napoli C, et al. Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation 2004;109:2109-2115.
26. Chade AR, Mushin OP, Zhu X, Rodriguez-Porcel M, Grande JP, Textor SC, et al. Pathways of renal fibrosis and modulation of matrix turnover in experimental hypercholesterolemia. Hypertension 2005;46:772-779.
27. Chade AR, Zhu XY, Grande JP, Krier JD, Lerman A, Lerman LO. Simvastatin abates development of renal fibrosis in experimental renovascular disease. J Hypertens 2008;26:1651-1660.
28. Wright JR, Shurrab AE, Cooper A, Kalra PR, Foley RN, Kalra PA. Progression of cardiac dysfunction in patients with atherosclerotic renovascular disease. QJM 2009;102:695-704.
29. Harding MB, Smith LR, Himmelstein SI, Harrison K, Phillips HR, Schwab SJ, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol 1992;2:1608-1616.
30. Urbieta-Caceres VH, Zhu XY, Gibson ME, Favreau FD, Jordan K, Lerman A, Lerman LO. Reversal of experimental renovascular hypertension restores coronary microvascular function and architecture. Am J Hypertens 2011;24:458-465.
31. Rodriguez-Porcel M, Lerman A, Herrmann J, Schwartz RS, Sawamura T, Condorelli M, et al. Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculature. Cardiovasc Res 2003;58:213-221.
32. Orrenius S. Reactive oxygen species in mitochondria-mediated cell death. Drug Metab Rev 2007;39:443-455.
33. Cho S, Szeto HH, Kim E, Kim H, Tolhurst AT, Pinto JT. A novel cellpermeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36. J Biol Chem 2007;282:4634-4642.
34. Gonzalez A, Ravassa S, Loperena I, Lopez B, Beaumont J, Querejeta R, et al. Association of depressed cardiac gp130-mediated antiapoptotic pathways with stimulated cardiomyocyte apoptosis in hypertensive patients with heart failure. J Hypertens 2007;25:2148-2157.
35. Buzello M, Boehm C, Orth S, Fischer B, Ehmke H, Ritz E, et al. Myocyte loss in early left ventricular hypertrophy of experimental renovascular hypertension. Virchows Arch 2003;442:364-371.
36. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 2009;119:573-581.
37. Lu Z, Xu X, Hu X, Fassett J, Zhu G, Tao Y, et al. PGC-1 alpha regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload. Antioxid Redox Signal 2010;13:1011-1022.
38. Ibarra-Lara L, Hong E, Soria-Castro E, Torres-Narvaez JC, Perez-Severiano F, Del Valle-Mondragon L, et al. Clofibrate PPARalpha activation reduces oxidative stress and improves ultrastructure and ventricular hemodynamics in no-flow myocardial ischemia. J Cardiovasc Pharmacol 2012;60:323-334.
39. Zhu XY, Daghini E, Chade AR, Rodriguez-Porcel M, Napoli C, Lerman A, Lerman LO. Role of oxidative stress in remodeling of the myocardial microcirculation in hypertension. Arterioscler Thromb Vasc Biol 2006;26:1746-1752.
40. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, Pennell DJ. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346:1948-1953.
41. Welch WJ, Mendonca M, Aslam S, Wilcox CS. Roles of oxidative stress and AT1 receptors in renal hemodynamics and oxygenation in the postclipped 2K, 1C kidney. Hypertension 2003;41:692-696.
42. Tousoulis D, Kampoli AM, Papageorgiou N, Antoniades C, Siasos G, Latsios G, et al. Matrix metallopropteinases in heart failure. Curr Top Med Chem 2012;12:1181-1191.
43. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997;74:111-122.